Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury Via Regulation of Necroptotic Neuronal Death and Inflammation: and
Overview
Affiliations
Necrotic cell death is a hallmark feature of ischemic stroke and it may facilitate inflammation by releasing intracellular components after cell-membrane rupture. Previous studies reported that β-caryophyllene (BCP) mitigates cerebral ischemia-reperfusion (I/R) injury, but the underlying mechanism remains unclear. We explored whether BCP exerts a neuroprotective effect in cerebral I/R injury through inhibiting necroptotic cell death and inflammation. Primary neurons with and without BCP (0.2, 1, 5, 25 μM) treatment were exposed to oxygen-glucose deprivation and re-oxygenation (OGD/R). Neuron damage, neuronal death type and mixed lineage kinase domain-like (MLKL) protein expression were assessed 48 h after OGD/R. Furthermore, mice underwent I/R procedures with or without BCP (8, 24, 72 mg/kg, ip.). Neurologic dysfunction, cerebral infarct volumes, cell death, cytokine levels, necroptosis core molecules, and HMGB1-TLR4 signaling were determined at 48 h after I/R. BCP (5 μM) significantly reduced necroptotic neurons and MLKL protein expression following OGD/R. BCP (24, 72 mg/kg, ip.) reduced infarct volumes, neuronal necrosis, receptor-interaction protein kinase-1 (RIPK1), receptor-interaction protein kinase-3 (RIPK3) expression, and MLKL phosphorylation after I/R injury. BCP also decreased high-mobility group box 1 (HMGB1), toll-like receptor 4 (TLR4), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) levels. Thus, BCP alleviates ischemic brain damage potentially by inhibiting necroptotic neuronal death and inflammatory response. This study suggests a novel application for BCP as a neuroprotective agent.
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.
Alraddadi E, Aljuhani F, Alsamiri G, Hafez S, Alselami G, Almarghalani D J Neuroimmune Pharmacol. 2025; 20(1):12.
PMID: 39899062 PMC: 11790784. DOI: 10.1007/s11481-025-10171-z.
β-Caryophyllene and Statins in Bone Fracture Healing - A Narrative Review.
Marom H, Khan M, Darvish N, Tornetta Iii P, Khoury A, Weil Y Orthop Res Rev. 2025; 17:31-42.
PMID: 39872403 PMC: 11771162. DOI: 10.2147/ORR.S506427.
Romano E, Dominguez-Rodriguez G, Mannina L, Cifuentes A, Ibanez E Int J Mol Sci. 2025; 26(2).
PMID: 39859317 PMC: 11765258. DOI: 10.3390/ijms26020601.
Prospects in the Use of Extracts in Nanoemulsions.
Vitola I, Angulo C, Baptista-Rosas R, Anaya-Esparza L, Escalante-Garcia Z, Villarruel-Lopez A BioTech (Basel). 2024; 13(4).
PMID: 39727490 PMC: 11674990. DOI: 10.3390/biotech13040053.
Lim C, Ogawa S, Kumari Y Arch Pharm Res. 2024; 48(1):1-42.
PMID: 39653971 DOI: 10.1007/s12272-024-01523-z.